Clinical Trials & REMS in the Time of Corona: FDA & MHRA Advice and Guidance

/ Apr 09, 2020

Pharmacovigilance expert Bart Cobert discusses the FDA and MHRA guidance for non-Corona related clinical trials.

Read More

Does Rapid FDA Approval Produce Drug Safety Issues?

/ Mar 16, 2020

Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.

Read More

Pharmacovigilance 2030

/ Dec 11, 2019

This is an interesting article looking at what PV will be in the year 2030.

Read More

Vaping – A Serious Safety Signal

/ Oct 07, 2019

Bart Cobert discusses the major safety issue in the US on e-cigarettes and vaping.

Read More

Importing Canadian Drugs to the US

/ Aug 29, 2019

Bart Cobert covers several issues involved in setting up the proposed "Safe Importation Plan" which aims to allow US consumers to get safe and cheaper drugs.

Read More

No-No’s in Drug Safety

/ Aug 13, 2019

An overview covering a number of things to avoid doing when it comes to drug safety.

Read More

Different Regulatory Actions from Different Agencies

/ Jun 27, 2019

Bart Cobert explores the potential reasons for the differing regulatory actions from the different agencies.

Read More

Reporting and Not Reporting Data

/ Jun 03, 2019

Bart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.

Read More

Medical Marijuana and Drug Safety

/ May 07, 2019

Bart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.

Read More

Guide to Causality Assessment

/ Mar 20, 2019

What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.

Read More